Effects of pioglitazone on coagulation and thrombosis in comparison to gliclazide in patients wtih type 2 diabetes

被引：0
|
作者：
Pampanelli, S
Rinaldi, T
Perriello, G
Brunetti, P
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：A140 / A140
页数：1
相关论文
共 50 条
  • [1] Effects of pioglitazone on liver function in comparison to gliclazide in patients with type 2 diabetes
    Perriello, G
    Pampanelli, S
    Di Pietro, C
    Brunetti, P
    DIABETES, 2004, 53 : A141 - A141
  • [2] Efficacy and safety of pioglitazone in comparison to gliclazide in patients with type 2 diabetes
    Perriello, G
    Pampanelli, S
    Di Pietro, C
    Brunetti, P
    DIABETES, 2004, 53 : A484 - A484
  • [3] A comparison of the effects of pioglitazone and gliclazide on metabolic control in drug-naive patients with type 2 diabetes
    Maher, L
    Edwards, G
    Lee, C
    Urquhart, R
    Johns, D
    Tan, M
    DIABETES, 2003, 52 : A461 - A461
  • [4] Cardiovascular effects of treatment of type 2 diabetes with pioglitazone, metformin and gliclazide
    Belcher, G
    Lambert, C
    Goh, KL
    Edwards, G
    Valbuena, M
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (09) : 833 - 837
  • [5] Long-term efficacy and safety of pioglitazone in comparison to gliclazide in patients with Type 2 diabetes
    Perriello, G
    Pampanelli, S
    Di Pietro, C
    Rinaldi, T
    Brunetti, P
    DIABETOLOGIA, 2004, 47 : A261 - A261
  • [6] Comparison of glycaemic control over 1 year with pioglitazone or gliclazide in patients with Type 2 diabetes
    Perriello, G
    Pampanelli, S
    Di Pietro, C
    Brunetti, P
    DIABETIC MEDICINE, 2006, 23 (03) : 246 - 252
  • [7] Comparison of pioglitazone and gliclazide in sustaining glycemic control over 2 years in patients with type 2 diabetes
    Tan, MH
    Baksi, A
    Krahulec, B
    Kubalski, P
    Stankiewicz, A
    Urquhart, R
    Edwards, G
    Johns, D
    DIABETES CARE, 2005, 28 (03) : 544 - 550
  • [8] Effects of Pioglitazone Add-On to Gliclazide and Metformin on Glycemic Control in Patients with Type 2 Diabetes
    Al-Azzam, Sayer I.
    AlOmari, Mousa
    Khader, Yousef S.
    AlMahasneh, Fatimah A.
    Muflih, Suhaib M.
    Altawalbeh, Shoroq
    ENDOCRINE RESEARCH, 2012, 37 (01) : 7 - 11
  • [9] Long-term effects of pioglitazone versus gliclazide on insulin sensitivity and lipids in patients with type 2 diabetes
    Charbonnel, B
    Roden, M
    Urquhart, R
    Mariz, S
    Edwards, G
    Johns, D
    Widel, M
    Mihm, M
    Tan, M
    DIABETES, 2004, 53 : A121 - A121
  • [10] Safety and tolerability of pioglitazone, metformin, and gliclazide in the treatment of type 2 diabetes
    Belcher, G
    Lambert, C
    Edwards, G
    Urquhart, R
    Matthews, DR
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 70 (01) : 53 - 62
12345